Swiss National Bank Cuts Stock Holdings in Axon Enterprise, Inc. (NASDAQ:AXON)

Swiss National Bank trimmed its position in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 4.7% during the fourth quarter, Holdings Channel.com reports. The fund owned 202,900 shares of the biotechnology company’s stock after selling 9,900 shares during the quarter. Swiss National Bank’s holdings in Axon Enterprise were worth $120,588,000 as of its most recent SEC filing.

A number of other hedge funds have also recently bought and sold shares of the company. Geode Capital Management LLC boosted its holdings in Axon Enterprise by 2.0% during the 3rd quarter. Geode Capital Management LLC now owns 1,782,828 shares of the biotechnology company’s stock worth $710,103,000 after acquiring an additional 35,320 shares during the last quarter. Westfield Capital Management Co. LP boosted its holdings in Axon Enterprise by 12.2% during the 3rd quarter. Westfield Capital Management Co. LP now owns 1,175,328 shares of the biotechnology company’s stock worth $469,661,000 after acquiring an additional 127,769 shares during the last quarter. Champlain Investment Partners LLC boosted its holdings in Axon Enterprise by 13.9% during the 3rd quarter. Champlain Investment Partners LLC now owns 682,420 shares of the biotechnology company’s stock worth $272,695,000 after acquiring an additional 83,265 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its holdings in shares of Axon Enterprise by 1.6% in the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 561,263 shares of the biotechnology company’s stock worth $224,281,000 after buying an additional 9,090 shares during the last quarter. Finally, Groupama Asset Managment purchased a new position in shares of Axon Enterprise in the 3rd quarter worth about $200,000. 79.08% of the stock is owned by hedge funds and other institutional investors.

Axon Enterprise Price Performance

NASDAQ AXON opened at $556.26 on Friday. The firm’s 50-day simple moving average is $594.32 and its two-hundred day simple moving average is $532.91. Axon Enterprise, Inc. has a 52 week low of $273.52 and a 52 week high of $715.99. The company has a market cap of $42.62 billion, a PE ratio of 143.74, a price-to-earnings-growth ratio of 5.17 and a beta of 1.12. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32.

Wall Street Analyst Weigh In

AXON has been the topic of a number of research analyst reports. Morgan Stanley raised shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and boosted their price target for the stock from $500.00 to $700.00 in a report on Tuesday, December 3rd. Barclays reissued a “hold” rating on shares of Axon Enterprise in a report on Monday. Northcoast Research downgraded shares of Axon Enterprise from a “buy” rating to a “neutral” rating in a report on Wednesday, February 19th. TD Cowen initiated coverage on shares of Axon Enterprise in a report on Wednesday, January 8th. They issued a “buy” rating and a $700.00 price target on the stock. Finally, JMP Securities reissued an “outperform” rating on shares of Axon Enterprise in a report on Tuesday, February 4th. One analyst has rated the stock with a sell rating, two have assigned a hold rating and eleven have assigned a buy rating to the company. According to MarketBeat, Axon Enterprise has a consensus rating of “Moderate Buy” and a consensus price target of $604.67.

Insider Activity

In related news, Director Michael Garnreiter sold 1,000 shares of the company’s stock in a transaction that occurred on Monday, December 16th. The shares were sold at an average price of $639.69, for a total value of $639,690.00. Following the transaction, the director now directly owns 24,259 shares in the company, valued at approximately $15,518,239.71. This represents a 3.96 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of the company’s stock in a transaction that occurred on Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total transaction of $271,831.50. Following the completion of the transaction, the director now owns 6,929 shares in the company, valued at approximately $4,185,601.03. This trade represents a 6.10 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 5,146 shares of company stock worth $3,262,847 over the last ninety days. Company insiders own 6.10% of the company’s stock.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.